Trademark: 88902639
Status Date
Tuesday, July 6, 2021
Registration Number
6406637
Registration Date
Tuesday, July 6, 2021
Filing Date
Wednesday, May 6, 2020
Published for Opposition
Tuesday, April 20, 2021
5 Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia in the nature of pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders
Jul 6, 2021
Registered-Principal Register
Apr 20, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 20, 2021
Published For Opposition
Mar 31, 2021
Notification Of Notice Of Publication E-Mailed
Mar 17, 2021
Approved For Pub - Principal Register
Mar 15, 2021
Teas/Email Correspondence Entered
Mar 15, 2021
Correspondence Received In Law Office
Mar 15, 2021
Teas Request For Reconsideration Received
Mar 1, 2021
Notification Of Final Refusal Emailed
Mar 1, 2021
Final Refusal E-Mailed
Mar 1, 2021
Final Refusal Written
Jan 27, 2021
Teas/Email Correspondence Entered
Jan 27, 2021
Correspondence Received In Law Office
Jan 27, 2021
Teas Response To Office Action Received
Aug 8, 2020
Notification Of Non-Final Action E-Mailed
Aug 8, 2020
Non-Final Action E-Mailed
Aug 8, 2020
Non-Final Action Written
Aug 1, 2020
Assigned To Examiner
May 18, 2020
New Application Office Supplied Data Entered In Tram
May 9, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
